AR030916A1 - PHARMACEUTICAL COMPOSITIONS OF VASOPRESINE AND DIURETIC ANTAGONISTS, KIT THAT UNDERSTAND AND USE THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT - Google Patents

PHARMACEUTICAL COMPOSITIONS OF VASOPRESINE AND DIURETIC ANTAGONISTS, KIT THAT UNDERSTAND AND USE THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT

Info

Publication number
AR030916A1
AR030916A1 ARP000105035A ARP000105035A AR030916A1 AR 030916 A1 AR030916 A1 AR 030916A1 AR P000105035 A ARP000105035 A AR P000105035A AR P000105035 A ARP000105035 A AR P000105035A AR 030916 A1 AR030916 A1 AR 030916A1
Authority
AR
Argentina
Prior art keywords
diuretic
manufacture
pharmaceutical compositions
vasopresine
antagonists
Prior art date
Application number
ARP000105035A
Other languages
Spanish (es)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of AR030916A1 publication Critical patent/AR030916A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Una composicion farmacéutica para aumentar el flujo de orina en humanos mientras que, al mismo tiempo, minimiza la pérdida de electrolitos o iones que comprende N-[4-(5H-pirrolo[2,1-c][1,4]benzodiazepin-10(11H)ilcarbonil)-3-clorofenil]-5-fluoro-2-metilbenzamida (o su sal farmacéuticamente aceptable), también conocida como VPA-985, y uno o más agentes diuréticos, así como también se refiere a las composiciones farmacéuticas y kits o envases para estas composiciones y el uso de éstas para la manufactura de un medicamento de un antagonista de vasopresina y diurético.A pharmaceutical composition for increasing urine flow in humans while, at the same time, minimizing the loss of electrolytes or ions comprising N- [4- (5H-pyrrolo [2,1-c] [1,4] benzodiazepin- 10 (11H) ilcarbonyl) -3-chlorophenyl] -5-fluoro-2-methylbenzamide (or its pharmaceutically acceptable salt), also known as VPA-985, and one or more diuretic agents, as well as refers to pharmaceutical compositions and kits or packages for these compositions and their use for the manufacture of a medicine of a vasopressin antagonist and diuretic.

ARP000105035A 1999-09-27 2000-09-26 PHARMACEUTICAL COMPOSITIONS OF VASOPRESINE AND DIURETIC ANTAGONISTS, KIT THAT UNDERSTAND AND USE THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AR030916A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40665899A 1999-09-27 1999-09-27

Publications (1)

Publication Number Publication Date
AR030916A1 true AR030916A1 (en) 2003-09-03

Family

ID=23608937

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105035A AR030916A1 (en) 1999-09-27 2000-09-26 PHARMACEUTICAL COMPOSITIONS OF VASOPRESINE AND DIURETIC ANTAGONISTS, KIT THAT UNDERSTAND AND USE THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT

Country Status (3)

Country Link
AR (1) AR030916A1 (en)
AU (1) AU7615100A (en)
WO (1) WO2001023366A2 (en)

Also Published As

Publication number Publication date
WO2001023366A2 (en) 2001-04-05
AU7615100A (en) 2001-04-30
WO2001023366A3 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
BR0015605A (en) Composition and use
BRPI0113331B8 (en) phenylalanine derivatives or their pharmaceutically acceptable salts, alpha 4 integrin antagonist, therapeutic agent or preventive agent for inflammatory diseases, and pharmaceutical composition
AR003116A1 (en) TRICYCLIC COMPOUNDS USEFUL TO INHIBIT THE FUNCTION OF PROTEIN G AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THE USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF MEDICINES
UY27760A1 (en) NEW DERIVATIVES OF PIRROLIDINIO.
ME00298B (en) Pharmaceutical composition
AR013506A1 (en) USE OF A PHARMACEUTICAL COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO BE USED IN THE TREATMENT OF DISEASES OF PULMONARCHRONIC OBSTRUCTION AND OF A KIT INCLUDING FORMOTEROL OR A SALT OR SOLVATE OF THE SAME AND BUDESONIDE
EA200400664A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING METHFORMIN AND GLIBENCLAMIDE, APPLIED TO THE TREATMENT OF TYPE II DIABETES
AR003938A1 (en) TRICYCLIC UREA COMPOUNDS USEFUL FOR THE INHIBITION OF THE FUNCTION OF PROTEIN G AND FOR THE TREATMENT OF PROTEOLYTIC DISEASES, PHARMACEUTICAL COMPOSITION, AND THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES.
PE20060485A1 (en) CONTRACEPTIVE REGIMES WITH PROGESTERONE RECEPTOR ANTAGONISTS AND KITS
BR0111206A (en) Arylmethylamine derivatives for use as tryptase inhibitors
ECSP055701A (en) NEW DERIVATIVES OF PYRIMIDINAMIDE AND THE USE OF THE SAME
BRPI0116237B8 (en) "sulfamide compound, pharmaceutical composition containing it and its use as an endothelin receptor antagonist drug".
BR0207715A (en) Compounds, pharmaceutical compositions, and use of one or more compounds
ES2192264T3 (en) MESYLATE SALT TRIHYDRATE OF 5- (2- (4- (1,2-BENZOISOTIAZOL-3-IL) -1-PIPERAZINIL) ETIL) -6-CHLORINE-1,3-DIHYDRO-2 (1H) -INDOL-2- ONA (= ZIPRASIDONA), ITS PREPARATION AND ITS USE AS A DOPAMINE ANTAGONIST.
AR002268A1 (en) BENZACEPINE TRICYCLIC VASOPRESIN ANTAGONISTS, A PROCEDURE FOR THEIR PREPARATION, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND THE USE OF SUCH COMPOUNDS TO PREPARE PHARMACEUTICAL COMPOSITIONS.
DE60037726D1 (en) CARBOXYLENE DERIVATIVES THAT RESTRICT THE BINDING OF INTEGRINES TO THEIR RECEPTORS
CO5631443A2 (en) DERIVATIVES OF 7-ARIL-3,9-DIAZABICICLO (3.3.1) NON-6-ENO AND ITS USE AS RHENINE INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES
BR9812492A (en) Compound, use of it, pharmaceutical formulation, and processes for the treatment of cardiovascular disease, for the treatment of vasoconstriction, and for the preparation of compounds
BR0111678A (en) Medicinal compositions containing propenone derivatives
BR9909486A (en) Calcilic compounds
SE0102055D0 (en) New Compounds
EA200200207A1 (en) APPLICATION OF CGRP ANTAGONISTS AND CGRP RELIEF INHIBITORS TO ELIMINATE TIDES IN THE PERIOD OF MENOPAUSE
ID28510A (en) NEW ORAL FORMULATION FOR AGONISTS OR 5-HT4 ANTAGONISTS
BRPI0409818A (en) compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds
BR0009674A (en) Compound, drug and compound use